tPA/HisproUK (Thrombolytic Science)

N/A

Report date: 2022/08/29 20:00:24

Base Information

Drug NametPA/HisproUK (Thrombolytic Science)
Drug Alias NameTS-01
ClassificationBiologics
Mechanisms of ActionUrokinase plasminogen activator stimulants
TargetsUrokinase plasminogen activator
Therapy Area/IndicationsIschemic Stroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesThrombolytic Science
China Registration ClassN/A

Develop Information

Active CompaniesDumas Is Sponsored By An Unrestricted Grant From Thrombolytic Science International, Paid To The Institution.
Inactive CompaniesTsi Llc
Active IndicationsIschemic Stroke
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A